Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan

BACKGROUND: Immune dysfunction in breast cancer patients is well established. Indoleamine 2,3-dioxygenase (IDO) is an immunosuppressive enzyme that is linked with progression of cancer. IDO is overexpressed in triple-negative breast cancer (TNBC) cases. MATERIALS AND METHODS: We conducted the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Asghar, Kashif, Loya, Asif, Rana, Iftikhar Ali, Tahseen, Muhammad, Ishaq, Muhammad, Farooq, Asim, Bakar, Muhammad Abu, Masood, Iqra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322492/
https://www.ncbi.nlm.nih.gov/pubmed/30655699
http://dx.doi.org/10.2147/CMAR.S184221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322492/
https://www.ncbi.nlm.nih.gov/pubmed/30655699
http://dx.doi.org/10.2147/CMAR.S184221

Ejemplares similares